ATE527272T1 - Synthese von triphenylphosphoniumchinolen und - chinonen - Google Patents

Synthese von triphenylphosphoniumchinolen und - chinonen

Info

Publication number
ATE527272T1
ATE527272T1 AT02760924T AT02760924T ATE527272T1 AT E527272 T1 ATE527272 T1 AT E527272T1 AT 02760924 T AT02760924 T AT 02760924T AT 02760924 T AT02760924 T AT 02760924T AT E527272 T1 ATE527272 T1 AT E527272T1
Authority
AT
Austria
Prior art keywords
quinones
sub
triphenylphosphoniumquinoles
synthesis
typified
Prior art date
Application number
AT02760924T
Other languages
English (en)
Inventor
Robin Smith
Michael Murphy
Original Assignee
Antipodean Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antipodean Pharmaceuticals Inc filed Critical Antipodean Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE527272T1 publication Critical patent/ATE527272T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fireproofing Substances (AREA)
AT02760924T 2001-08-13 2002-08-12 Synthese von triphenylphosphoniumchinolen und - chinonen ATE527272T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ513547A NZ513547A (en) 2001-08-13 2001-08-13 Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone)
PCT/NZ2002/000154 WO2003016323A1 (en) 2001-08-13 2002-08-12 Synthesis of triphenylphosphonium quinols snd quinones

Publications (1)

Publication Number Publication Date
ATE527272T1 true ATE527272T1 (de) 2011-10-15

Family

ID=19928579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02760924T ATE527272T1 (de) 2001-08-13 2002-08-12 Synthese von triphenylphosphoniumchinolen und - chinonen

Country Status (5)

Country Link
US (1) US7179928B2 (de)
EP (1) EP1423396B1 (de)
AT (1) ATE527272T1 (de)
NZ (1) NZ513547A (de)
WO (1) WO2003016323A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019233A1 (en) * 2003-08-22 2005-03-03 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
US20080275005A1 (en) * 1998-11-25 2008-11-06 Murphy Michael P Mitochondrially targeted antioxidants
US20060229278A1 (en) * 1998-11-25 2006-10-12 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
CN1839142B (zh) * 2003-08-22 2010-06-16 澳新制药公司 用作靶向线粒体的抗氧化剂的线粒体醌衍生物
US7888334B2 (en) 2003-08-22 2011-02-15 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
CN1997403A (zh) * 2004-07-13 2007-07-11 奥里迪斯生物医学研究及开发有限责任公司 靶向线粒体的抗氧化剂在治疗肝病和上皮癌中的用途
EP1888059B1 (de) * 2005-06-01 2014-12-17 Edison Pharmaceuticals, Inc. Redoxaktive therapeutik zur behandlung von mitochondrialen erkrankungen und anderen zuständen sowie modulation von energie-biomarkern
PL1933821T3 (pl) * 2005-09-15 2021-01-11 Ptc Therapeutics, Inc. Warianty łańcucha końcowego środków terapeutycznych o aktywności redoks do leczenia chorób mitochondrialnych i innych stanów oraz do modulacji biomarkerów energetycznych
JP5374162B2 (ja) 2006-02-22 2013-12-25 エジソン ファーマシューティカルズ, インコーポレイテッド ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
EP2617417A1 (de) 2006-02-22 2013-07-24 Edison Pharmaceuticals, Inc. Seitenkettenvarianten von redoxaktiven Therapeutika zur Behandlung von mitochondrialen Erkrankungen und anderen Zuständen sowie Modulation von Energie-Biomarkern
JP2010515736A (ja) * 2007-01-10 2010-05-13 エジソン ファーマシューティカルズ, インコーポレイテッド エリスロポイエチン活性またはトロンボポイエチン活性を有する化合物を用いる呼吸鎖障害の治療
EP3456707B1 (de) 2007-11-06 2020-04-15 PTC Therapeutics, Inc. 4-(p-quinonyl)-2-hydroxybutanamid-derivate zur behandlung von mitochondrialen erkrankungen
EA023618B1 (ru) 2008-01-08 2016-06-30 Эдисон Фармасьютикалз, Инк. Производные (гет)арил-п-хинона для лечения митохондриальных болезней
EP2262508B1 (de) 2008-03-05 2018-10-03 BioElectron Technology Corporation SUBSTITUIERTE p-CHINONDERIVATE ZUR BEHANDLUNG VON ERKRANKUNGEN IN VERBINDUNG MIT OXIDATIVEM STRESS
EA201001814A1 (ru) * 2008-05-22 2011-04-29 Эдисон Фармасьютикалз, Инк. Лечение митохондриальных заболеваний миметиками эритропоэтина
EP2303824B1 (de) * 2008-06-25 2015-03-25 Edison Pharmaceuticals, Inc. 2-heterocyclylaminoalkyl-(p-chinon)-derivate zur behandlung von krankheiten mit oxidativem stress
LT3827815T (lt) 2008-09-10 2023-10-10 Ptc Therapeutics, Inc. Psichologinių raidos sutrikimų gydymas oksidacijos redukcijos atžvilgiu aktyviais vaistais
JP6093756B2 (ja) 2011-04-26 2017-03-08 レトロトップ、 インコーポレイテッドRetrotope, Inc. 損なわれたエネルギー処理障害およびミトコンドリア欠損症
ES2859753T3 (es) 2011-04-26 2021-10-04 Retrotope Inc Trastornos que implican la oxidación de PUFA
EP3689342A1 (de) 2011-04-26 2020-08-05 Retrotope, Inc. Oxidative netzhauterkrankungen
KR102020611B1 (ko) 2011-04-26 2019-09-10 레트로토프 인코포레이티드 Pufa와 관련된 신경퇴행성 질환 및 근육 질환
SI2872497T2 (sl) 2012-07-12 2019-12-31 Khondrion Ip B.V. Derivati kromanila za zdravljenje mitohondrijske bolezni
CA2883879A1 (en) 2012-09-07 2014-03-13 Edison Pharmaceuticals, Inc. Quinone derivatives for use in the modulation of redox status of individuals
EP2970158B1 (de) 2013-03-15 2019-02-20 BioElectron Technology Corporation Alkyl-heteroarylsubstituierte chinonderivate zur behandlung von oxidativen stresserkrankungen
US9868711B2 (en) 2013-03-15 2018-01-16 Bioelectron Technology Corporation Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US9296712B2 (en) 2013-03-15 2016-03-29 Edison Pharmaceuticals, Inc. Resorufin derivatives for treatment of oxidative stress disorders
US20140275045A1 (en) 2013-03-15 2014-09-18 Edison Pharmaceuticals, Inc. Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US9670170B2 (en) 2013-03-15 2017-06-06 Bioelectron Technology Corporation Resorufin derivatives for treatment of oxidative stress disorders
JP2016520621A (ja) 2013-05-31 2016-07-14 エジソン ファーマシューティカルズ, インコーポレイテッド 酸化ストレス障害の処置のためのカルボン酸誘導体
CN106170206A (zh) 2014-03-13 2016-11-30 乐巢拓普有限公司 视神经病变治疗和用稳定的多不饱和物质减少类固醇诱导的氧化应激
US9314457B2 (en) 2014-06-19 2016-04-19 The University Of Utah Research Foundation Methods of treating and preventing vascular instability diseases
SG10202003299PA (en) 2014-12-16 2020-05-28 Ptc Therapeutics Inc Polymorphic and amorphous forms of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
US10815211B2 (en) 2015-10-08 2020-10-27 Khondrion Ip B.V. Compounds for treating mitochondrial disease
JP6905527B2 (ja) 2015-12-17 2021-07-21 ピーティーシー セラピューティクス, インコーポレイテッド 酸化ストレス障害を処置するためのフルオロアルキル、フルオロアルコキシ、フェノキシ、ヘテロアリールオキシ、アルコキシ、およびアミノ1,4−ベンゾキノン誘導体
CN110167546A (zh) 2016-11-17 2019-08-23 乐巢拓普有限公司 同位素修饰的组分及其治疗用途
WO2018129411A1 (en) 2017-01-06 2018-07-12 Bioelectron Technology Corporation Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders
CN109793720B (zh) * 2019-01-28 2022-01-14 温州医科大学 一种基于透明质酸的线粒体靶向抗氧化剂Mito Q纳米制剂的制备方法及应用
EP3983385B1 (de) 2019-06-13 2023-08-30 PTC Therapeutics, Inc. Naphthochinonderivate zur behandlung von erkrankungen in verbindung mit oxidativem stress
KR20210076875A (ko) * 2019-12-16 2021-06-24 주식회사 스마틴바이오 신생혈관형성인자의 억제를 위한 화합물 및 그 용도
WO2022019362A1 (ko) * 2020-07-24 2022-01-27 울산과학기술원 Tpp 유도체 화합물 및 이를 포함하는 노화 또는 노화 관련 질환의 치료 또는 예방을 위한 약학적 조성물
US11389431B2 (en) 2020-09-09 2022-07-19 Social Profit Network Methods and compositions for delivery of biotin to mitochondria
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS
WO2026008715A1 (en) 2024-07-02 2026-01-08 Université Catholique de Louvain Mitochondrially-targeted antioxidant compound for use in radiation therapy
CN118994239B (zh) * 2024-08-09 2025-09-26 苏州满元生物科技有限公司 氧化制备米托醌的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0237338B2 (ja) 1982-08-27 1990-08-23 Takeda Chemical Industries Ltd 99*3*44jimetokishii22hidorokishii66mechirubenzoiru*nonanoeetonoseizoho
EP0289223B1 (de) 1987-04-27 1992-09-02 Takeda Chemical Industries, Ltd. Reduktion von Carbonsäureestern
JPH07223991A (ja) 1993-12-17 1995-08-22 Takeda Chem Ind Ltd アシル置換芳香族化合物の製造法
JP2637705B2 (ja) 1995-03-02 1997-08-06 株式会社ナード研究所 ベンゾキノン系誘導体の製造法
US6331532B1 (en) 1998-11-25 2001-12-18 University Of Otago Mitochondrially targeted antioxidants

Also Published As

Publication number Publication date
NZ513547A (en) 2002-09-27
US20050043553A1 (en) 2005-02-24
EP1423396B1 (de) 2011-10-05
WO2003016323A1 (en) 2003-02-27
EP1423396A1 (de) 2004-06-02
US7179928B2 (en) 2007-02-20
EP1423396A4 (de) 2006-02-22

Similar Documents

Publication Publication Date Title
ATE527272T1 (de) Synthese von triphenylphosphoniumchinolen und - chinonen
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
ATE270817T1 (de) Fungizide
DK1200418T3 (da) Nematodicide trifluorbutener
TR200001876T2 (tr) HIV proteaz inhibitörünün bisülfat tuzu.
RU96119782A (ru) Производные 7-амино-1h-индола
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1113657T1 (el) Νεα παραγωγα βενζοφαινονης ή αλατα αυτων
BR0209984A (pt) Processo para a preparação de prostaglandinas e seus análogos
DK1100789T3 (da) Substituerede benzoylcyclohexandioner
SE0004245D0 (sv) Novel compounds and their use
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
HRPK20030233B3 (en) Process for the preparation of substituted phenylacetonitriles
EA199900790A1 (ru) Способы получения пестицидных промежуточных соединений
DE60123034D1 (de) Herstellung von sekundären aminoisobutylalkoxysilanen
EA200100129A1 (ru) Способ получения гидроксиметилтиобутановой кислоты
TR200402547T4 (tr) Pantoprazol ve ara maddelerini hazırlamak için bir işlem.
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
TR200402546T4 (tr) Taksan türevleri hazırlamak için işlem.
ES2055503T3 (es) Diimida de silicio y procedimiento para su fabricacion, y para la fabricacion de nitruro de silicio generado a partir de la misma.
MXPA04004937A (es) Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
TR200400293T4 (tr) 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.
ECSP034920A (es) Proceso para la preparacion de derivados de ciclohexanol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties